Structure (Methylprednisolone Sodium Succinate For Injection 1)
Methylprednisolone Sodium Succinate Injection, Powder, For Solution
Product Images NDC 72572-097
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Sodium Succinate (NDC 72572-097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Vial Label (Methylprednisolone Sodium Succinate For Injection 2)
This text describes a medication called Methylprednisolone Sodium Succinate for injection, USP, with a concentration of 40 mg per vial. It is intended for intramuscular or intravenous use only and should be reconstituted with specific diluents. The usual dosage instructions can be found in the package insert, and it should be protected from light. Unused portions should be discarded. The medication is distributed by Civica, Inc., and manufactured by Hikma Farmaceutica in Portugal.*
Carton Label (Methylprednisolone Sodium Succinate For Injection 3)
This text contains information about a medication called methylPREDNISolone Sodium Succinate for Injection, USP, with a dosage of 40 mg per vial. The medication is intended for intramuscular or intravenous use only. It provides instructions on how to open the vials and store the solution. The usual dosage information is also included, along with the recommendation to store the medication at a specific temperature range. Additionally, the text mentions the need to protect the solution from light and to discard any unused portion.*
Vial Label (Methylprednisolone Sodium Succinate For Injection 4)
This text provides information about methylPREDNISOLONE, a medication used for injection, either intramuscularly or intravenously. It mentions the dosage and instructions for use, including mixing with Sodium Succinate. The product appears to be intended for single-dose use and is accompanied by a reference to FDA standards.*
Carton Label (Methylprednisolone Sodium Succinate For Injection 5)
This text is a comprehensive drug label for Methylprednisolone Sodium Succinate for Injection, USP, with a concentration of 125 mg per vial. It provides instructions for reconstitution, dosage guidelines, storage conditions, and precautions. The medication is intended for intramuscular or intravenous use only, and the package includes 25 single-dose vials. The text also instructs on the use of Water for Injection USP or Bacteriostatic Water for Injection USP for reconstitution. It stresses the need to protect the solution from light, discard unused portions, and provides contact information for distribution.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
